Skip to main content
Experimental and Therapeutic Medicine logoLink to Experimental and Therapeutic Medicine
. 2015 Sep 18;10(5):1896–1902. doi: 10.3892/etm.2015.2753

Predictors of prognosis in patients with temporal lobe epilepsy after anterior temporal lobectomy

ZHENXING SUN 1,*, HUANCONG ZUO 1, DAN YUAN 2, YAXING SUN 3, KAI ZHANG 4,*, ZHIQIANG CUI 1, JIN WANG 5,
PMCID: PMC4665355  PMID: 26640569

Abstract

The aim of this study was to evaluate the predictive value of prognostic factors for the surgical outcome of patients with mesial temporal lobe epilepsy (MTLE) using Engel seizure classification. The clinical data of 121 patients with MTLE who underwent anterior temporal lobectomy (ATL) and received a 1-year minimum follow-up were collected between January 2005 and December 2008. Patients were divided into seizure and seizure-free groups according to the Engel seizure classification. Univariate analysis and multivariate logistic regression analysis were used to analyze the potential predictive and prognostic factors, including medical history, clinical features of seizures, magnetic resonance imaging (MRI) and video-electroencephalogram (EEG) monitoring results. Univariate analysis indicated no statistically significant differences in gender, age at seizure onset, age at surgery, history of traumatic brain injury, perinatal anoxia, intracranial infection, family history of seizure, auras or site of surgery between the two groups; however, significant differences were detected in pre-surgical seizure duration, history of febrile seizures, seizure types, MRI and video-EEG results. Multivariate logistic regression analysis demonstrated that a pre-surgical seizure duration of <10 years, history of positive febrile seizures, simple complex partial seizure, positive MRI results and unilateral local video-EEG spikes may be considered as predictors of a good prognosis. These results indicate that remission may be achieved in patients with MTLE via the collection of accurate clinical information and adequate pre-surgical evaluation.

Keywords: anterior temporal lobectomy, mesial temporal lobe epilepsy, predictor, prognosis

Introduction

Mesial temporal lobe epilepsy (MTLE) is the most common type of medically refractory epilepsy syndrome in adolescents and adults. MTLE usually presents at the inner aspect of the temporal lobe, and typically affects the hippocampus, parahippocampal gyrus and amygdala (1,2). The pathophysiological substrate of this disease is usually hippocampal sclerosis (HS) (3). However, certain cases of MTLE present without the typical changes of mesial temporal sclerosis or other abnormalities on magnetic resonance imaging (MRI) scans (MRI-negative), and the seizure outcome is poor (4). Previous studies have demonstrated that surgery is a more effective therapeutic approach for epilepsy compared with anti-epileptic drugs (AEDs) in the majority of patients with MTLE (57). For this reason, certain scholars consider surgery to be the first choice of treatment for MTLE. Anterior temporal lobectomy (ATL) is the most commonly used surgical technique for treating MTLE. McIntosh et al (6) provided a systematic review summarizing 126 articles published between 1991 and 2001, and demonstrated that 60–70% of patients with MTLE were free of seizures following ATL surgery. However, the remaining ~30% of patients continue to experience seizures to a certain extent, the cause of which remains unclear. The primary goal of epilepsy surgery is to achieve the long-term prevention of seizures. However, numerous studies have reported that the long-term prognosis is relatively poor compared with the short-term prognosis (615). The causes for long-term worsening of the surgical outcome are also unknown and the predictive factors of short-term and long-term prognosis may differ.

Therefore, it is crucial to investigate the predictive indicators of long-term outcome in patients with MTLE, which may improve general understanding of the causes of surgical failure. However, few studies have evaluated the influence of pre-surgical factors including medical history, clinical features of seizures, MRI and video-electroencephalography (EEG) monitoring results on the efficacy of epilepsy surgery, particularly on the long-term prevention of seizures. Accordingly, it is necessary to understand how to predict the prognosis from pre-surgical factors and select patients for surgery in order to improve the seizure-free rate in patients with MTLE. Therefore, in the present study, the clinical data of 121 patients with MTLE who underwent an ATL was analyzed, with at least 1 year of follow-up. Patients were allocated into different groups according to Engel seizure classification in order to evaluate the surgical results in terms of seizure outcomes, and to further analyze the potential value of predictive factors associated with long-term efficacy.

Subjects and methods

Subjects and inclusion criteria

A total of 162 patients with medically refractory temporal epilepsy syndrome that underwent ATL in Tiantan Hospital (Beijing, China) were recruited between January 2005 and December 2008. The inclusion criteria were as follows: i) All patients presented the clinical characteristics of MTLE for >1 year and had adequate trial of at ≥3 first-line antiepileptic drugs for >2 years, but continued to suffer from seizures; ii) continuous non-invasive 32-channel video scalp EEG monitoring (including sphenoidal electrodes to determine ictal and interictal focal activity for ≥7 days) supported the characteristics of MTLE; iii) MRI (1.5T scanners) and/or histopathological findings were characteristic of HS. The histopathological findings associated with HS were neuronal loss and glial proliferation in the hippocampal subfields CA1 and CA3 or in the dentate gyrus (1618). The MRI findings associated with HS were decreased hippocampal volume secondary to neuronal loss, and increased hippocampal T2 signal secondary to gliosis (1618). This study was supported by the ethics committee of Tsinghua University (Beijing, China). Informed consent was obtained from the patients for the use of their data.

Pre-surgical evaluation

The pre-surgical evaluation program was as follows: i) Medical histories included perinatal anoxia, family history of seizure, febrile seizures, intracranial infection and traumatic brain injury; ii) clinical data included gender, pre-surgical duration, auras, age at seizure onset, duration of seizure, types of seizure, seizure frequency per month prior to surgery, location of surgery and age at surgery; iii) diagnostic examination included MRI and video-EEG via scalp/sphenoidal electrodes, single photon emission computed tomography or positron emission tomography or magnetoencephalography of relevant areas of patients.

Surgical procedure

Following an ipsilateral frontotemporal craniotomy, all patients underwent cerebral cortex and deep EEG monitoring. The surgical approach adopted ATL during which the anterior 4–5 cm of the temporal tip for the dominant hemisphere and 5–6 cm for the non-dominant one were resected, as were the mesial structures including the areas of amygdala, hippocampus and parahippocampal gyrus. The extent of resection was adjusted on the basis of intraoperative electrocorticogram (ECoG) monitoring. All surgeries were performed by the same neurosurgeon and no patients underwent a second surgery.

Follow-up

Postoperative follow-up data regarding seizure outcomes, including clinical auras, seizure frequency and duration of seizure, were obtained via standardized telephone interviews performed by one of the authors. Patients were assigned to outcome classes in relation to seizure control based on the Engel seizure classification, which was as follows: Class I, free of disabling seizures; class II, rare disabling seizures, almost seizure-free; class III, worthwhile improvement; and class IV, no worthwhile improvement.

Data collection and statistical analysis

The pre-surgical seizure duration was grouped as <10 years and ≥10 years. According to the international classification of epileptic seizures (19), seizure types were divided into simple complex partial seizures (CPS), frequent CPS and frequent generalized tonic-clonic seizures (GTCS) based on whether the CPS was accompanied by GTCS or not. The MRI data were classed as positive and negative according to whether HS was present or not (Fig. 1). Patients were further classified as exhibiting unilateral local lobe, unilateral multi-lobe or bilateral lobe seizures, based on the characteristics of the video-EEG.

Figure 1.

Figure 1.

Representative micrographs of magnetic resonance images showing hippocampal sclerosis or normal hippocampus. (A) Left hippocampus appeared atrophied and hyperintense on the T2-weighted images, which was diagnosed as hippocampal sclerosis (HS). (B) Cortical dysplasia in the left temporal lobe with left HS. (C) Cortical atrophy in the left temporal lobe with HS. (D) The temporal horn in the right lateral ventricle was expanded with a normal hippocampus.

Regarding seizure outcome, patients were divided into two categories: Seizure-free group (Engel classification, I) and seizure group (Engel classification, II–IV). Patients with non-disabling auras, but without seizures, were considered to be seizure-free. Seizure freedom was defined as those patients that were seizure-free from the day of surgery to the last outcome assessment, or were seizure-free for >2-years post surgery.

An independent sample t-test or Rank sum test was used to analyze the quantitative variables: Age at seizure onset, pre-surgical duration, duration of seizure, seizure frequency per month prior to surgery and age at surgery. A Pearson's χ2, continuity correction or Fisher's exact test was used to analyze the following qualitative variables: Gender, presence of auras, history of perinatal anoxia, family history of seizure, febrile seizures, intracranial infection and traumatic brain injury, location of surgery and MRI data. Row × Column (RxC) contingency table χ2 and subdivided RxC table independence tests were used for the analysis of seizure types and distributing range of spikes in the video-EEG. Backward stepwise multiple logistic regression analysis was used to assess the possible predicting factors of prognosis. Using SPSS software, version 16.0 (SPSS, Inc., Chicago, IL, USA) P<0.017 was considered to indicate a statistically significant difference in the subdividing RxC table tests, and P<0.025 was considered to indicate a statistically significant difference for the other statistical methods.

Results

Patient characteristics

Among the total of 162 patients with ATL, 123 (75.9%) exhibited MTLE/HS, 14 (8.6%) gliomas, 4 (2.5%) heterotopic gray matter, 5 (3.1%) cavernous malformation, 8 (4.9%) cerebral dysgenetic lesions and 8 (4.9%) arachnoid cysts. A total of 121 patients (98.4%, 63 men and 58 women) among the 123 patients with MTLE/HS were adequately followed-up. The mean follow-up period was 3.33±0.89 years (range, 1–5 years). The mean patient ages at seizure onset and at surgery were 16.35±12.29 years (range, 4–34 years) and 27.55±11.58 years (range, 5–54 years), respectively. The mean patient pre-surgical seizure period was 10.90±7.50 years (range, 2–35 years). Among the 121 patients that received follow-up, 83 cases possessed a history relating to seizures, including 63 cases with febrile seizures (including 43 simple febrile seizures without secondary diseases, 7 cases secondary to intracranial infection and 13 cases secondary to traumatic brain injury), 19 cases with traumatic brain injury, 7 cases with intracranial infection, 12 cases with perinatal anoxia and 2 cases with a family history of seizures. The numbers of patients that underwent ATL on the left and right side were 61 (50.4%) and 60 (49.6%), respectively (Table I).

Table I.

Patient characteristics.

Parameter Value
Gender, M/F 63/58
Follow-up period, years
  Mean 3.33±0.89
  Range 1–5
Age at seizure onset, years
  Mean 16.35±12.29
  Range 4–34
Age at surgery, years
  Mean 27.55±11.58
  Range 5–54
Pre-surgical seizure duration, years
  Mean 10.90±7.50
  Range 2–35
History associated with seizure, n (%) 83 (68.6)
  Febrile seizures, n (%) 63 (52.1)
  Traumatic brain injury, n (%) 19 (15.7)
  Intracranial infection, n (%)   7 (5.8)
  Perinatal anoxia, n (%) 12 (9.9)
  Family history of seizures, n (%)   2 (1.7)
Surgery location, n (%)
  Left side 61 (50.4)
  Right side 60 (49.6)
Clinical auras, n (%) 57 (47.1)
  Gastric gas 11 (9.1)
  Palpitation 13 (10.7)
  Headache 7 (5.8)
  Fear 17 (14.0)
  Déjà-vu 6 (5.0)
  Euphoria 1 (0.8)
  Sadness 2 (1.7)
Automatism, n (%) 53 (43.8)
  Oroalimentary 22 (18.2)
  Gestural 25 (20.7)
  Verbal 6 (5.0)
Seizure types, n (%)
  Single CPS 30 (24.8)
  Frequent CPS 72 (59.5)
  Frequent GTCS 19 (15.7)
Video-EEG results, n (%)
  Unilateral lobe 90 (74.4)
  Unilateral multi-lobe 17 (14.0)
  Bilateral lobes 14 (11.6)
Evidence of HS, n (%)
  MRI 101 (83.5)
  Histopathology 115 (93.4)

M/F, male/female; CPS, complex partial seizures; GCTS, generalized tonic-clonic seizures; EEG, electroencephalogram; HS, hippocampal sclerosis; MRI, magnetic resonance imaging.

Among the 57 patients with auras, 11 cases presented with adverse rising of gastric gas, 13 cases had palpitations, 7 cases suffered from headache, 17 cases experienced fear, 6 cases had déjà-vu, 1 case experienced euphoria and 2 cases exhibited sadness, as observed by the doctor. In addition, 53/121 patients (43.8%) had automatism, including 22 cases of oroalimentary automatism, 25 cases of gestural automatism and 6 cases of verbal automatism. With regard to seizures, there were 30 patients (24.8%) with CPS, 72 patients (59.5%) with frequent CPS and 19 patients (15.7%) with frequent GTCS. The results of the video-EEG showed that in 90 patients (74.4%) the unilateral local lobe was involved in the seizure onset, 17 patients (14.0%) had unilateral multi-lobe involvement and 14 patients (11.6%) had bilateral lobe involvement. Among the 121 patients, 101 cases (83.5%) presented with indications of HS under MRI examination, and 115 cases (93.4%) had a diagnosis of HS confirmed by histopathological analysis (the remaining 6 patients were not available for histopathological examination but were confirmed to have HS using MRI). Therefore, all patients received a confirmed diagnosis of HS using MRI or histopathological analysis, including 20 patients in whom MRI did not reveal HS, and 95 patients (78.5%) in whom HS was confirmed by MRI and histopathological results (Table I).

Engel classification

In total, 87 patients (71.9%) received an Engel classification of class I and formed the seizure-free group. In addition, 3 (2.5%), 18 (14.9%) and 13 patients (10.7%) were categorized as Engel class II, III and IV, respectively, and were grouped together as the seizure group. Furthermore, 87/121 (71.9%), 83/116 (71.6%), 69/91 (75.8%), 41/52 (78.8%) and 11/16 (68.8%) patients satisfied the criteria of Engel Class I at years 1–5 of follow-up, respectively. Year-by-year seizure outcomes based on Engel's classification are presented in Table II and Fig. 2.

Table II.

Year-by-year seizures by Engel class.

Patients, n (%)

Follow-up Class I Classes II–IV
1 year 87/121 (71.9) 34/121 (28.1)
2 years 83/116 (71.6) 33/116 (28.4)
3 years   69/91 (75.8)   22/91 (24.2)
4 years   41/52 (78.8)   11/52 (21.2)
5 years   11/16 (68.8)     5/16 (31.2)
Figure 2.

Figure 2.

Patient outcome in the Engel class I (seizure-free) group was improved compared with that of the class II–IV (seizure) group. Year-by-year seizure outcomes were analyzed based on Engel's classification during the 5-year follow-up period.

Identification of variables distinguishing between seizure and seizure-free groups

Univariate analysis indicated no statistically significant difference between the seizure and seizure-free groups in gender, age at onset of seizures, age at surgery, history of traumatic brain injury, perinatal anoxia, intracranial infection, family history of seizures, presence of auras and site of surgery. By contrast, significant differences were detected in pre-surgical duration <10 years, history of febrile seizures, seizure type, MRI and video-EEG results between the two groups. The outcomes of analyses between the seizure-free and seizure groups are presented in Tables IIIV.

Table III.

Analysis of identifying variables between seizure-free and seizure groups.

Quantitative variables Seizure-free (n=87) Seizure (n=34) P-value
t-test
  Age at surgery (years) 26.97±11.70 29.21±11.81 0.347
  Age at onset of seizure (years) 16.44±12.33 16.12±12.37 0.897
  Pre-surgical duration (years) 10.39±7.56 11.89±7.61 0.329
Rank sum test
  Duration of seizures (sec) 136.67±170.44 146.67±218.20 0.908
  Seizure frequency (n/month) 23.37±46.34 40.94±83.81 0.935

Quantitative results are expressed as the mean ± standard deviation.

Table V.

Analysis of identifying variables between seizure-free and seizure groups.

Qualitative variables Seizure-free (n=87) Seizure (n=34) P-value
Video-EEG results 0.003
  Bilateral lobes   7   7
  Unilateral multi-lobes   8   9
  Unilateral local lobe 72 18
Seizure types 0.001
  Frequent GTCS   7 12
  Frequent CPS 57 15
  Simple CPS 23   7

RxC contingency tables and χ2 tests were used for statistical analysis. EEG, electroencephalogram; GTCS, generalized tonic-clonic seizures; CPS, complex partial seizures.

The Rank sum test indicated no statistically significant difference between the seizure and seizure-free groups with regard to duration of seizures and seizure frequency prior to surgery. However, the RxC χ2 test revealed a statistically significant difference in video-EEG results and seizure types between the two groups. Furthermore, the subdividing RxC table test showed that the seizure outcomes for unilateral local lobe involvement differed in comparison with those for multiple lobe involvement (including unilateral multi-lobes and bilateral lobes) and that seizure outcomes involving CPS differed from those of frequent CPS and frequent GTCS (Table V).

On the basis of a backward stepwise multiple logistic regression analysis, the presence of a number of pre-surgical risk factors, including pre-surgical seizure duration, history of febrile seizures, seizure types, MRI and video-EEG results were associated with poor prognosis. However, other factors, including gender, presence of auras, age at seizure onset, age at surgery, duration of seizures, seizure frequency per month prior to surgery, history of perinatal anoxia, intracranial infection or traumatic brain injury, and a family history of seizure were not associated with prognosis (Table VI).

Table VI.

Backward stepwise multiple logistic regression.

Engel classification

Parameter Regression coefficient P-value
Pre-surgical seizure duration <10 years   1.100 0.019
History of febrile seizures   1.755 0.002
Seizure types   1.232 0.017
Video-EEG findings   1.321 0.012
MRI (positive)   1.441 0.005
Constant −7.500 0.001

EEG, electroencephalogram; MRI, magnetic resonance imaging.

Discussion

MTLE is the most common type of temporal lobe epilepsy (TLE), and surgery is the most effective treatment available at present for this condition (1,2,5,6,20). Since the causes of surgical failure are not understood, epilepsy surgery is underutilized. Surgical approaches include ATL, amygdalohippocampectomy and lesionectomy/corticectomy. Various alternative methods of resecting MTLE have been discussed since ATL was first developed by Falconer and Taylor (21). However, at present ATL remains the predominant surgical option for MTLE (57) and the seizure outcomes following ATL have been extensively studied (68,18). Prognostic factors for the long-term surgical outcomes of MTLE include early postoperative seizures (22,23), duration of seizures (24,25), age at surgery (2426), history of febrile seizures (11,27), concordant interictal epileptiform abnormalities (20,28,29) and GTCS or the presence of status epilepticus prior to surgery (7,10,29,30). However, there are few systematic studies regarding the prediction of long-term seizure-free outcome following ATL. In addition, the previous studies regarding the surgical outcomes of MTLE are conflicting. The discrepancies in these predictive factors may be associated with the differences in the pathological substrates used and methodological problems of the study population (6,31).

The aim of the present study was to identify prognostic factors that are able to predict the surgical outcome in patients with MTLE at 1–5 years after ATL, according to the well-established Engel classification system. The results of 121 patients that had undergone a range of pre-surgical evaluations, including medical history, clinical presentation, MRI and video-EEG observations, are reported. Among these patients, 71.9% with MTLE became seizure free and the remaining 28.1% patients continued to exhibit seizure symptoms at the first follow-up period, which was consistent with the results of previous studies (6,7,26). Seizure relief rates have ranged between 67 and 84% for the surgical treatment of MTLE in recent studies (6,7,26) with a median rate of ~70% (6). This outcome may further support the use of early ATL for the treatment of MTLE. However, in the present study, the seizure-free rate of the patients had decreased by 5 years after surgery and the seizure-free rates >5 years after surgery are unknown. Therefore, the therapeutic efficacy of surgery after 5 years cannot be predicted. Furthermore, certain predictors of the long-term surgical outcomes following ALT for MTLE may differ from the variables that predict short-term outcome. In the present study, univariate and multivariate analyses indicated that factors including pre-surgical seizure duration, history of febrile convulsions, seizure types, MRI and video-EEG results exhibited statistically significant differences between the seizure and seizure-free group, and these factors were associated with the surgical outcomes of the patients.

In the present study, of the 64 patients with a seizure duration <10 years, 41 (64%) were in the seizure-free group and 23 (36%) were in the seizure-free group. Of the 57 patients with a pre-surgical seizure duration of ≥10 years, 46 patients (80.7%) belonged to the seizure-free group and 11 patients (19.3%) were in the seizure group. The Pearson's χ2 test indicated a statistically significant difference in seizure outcome between the two groups (P=0.042). Backward stepwise logistic regression further demonstrated that a pre-surgical duration of <10 years predicted a seizure-free 5-year outcome. In addition, previous studies have demonstrated that patients with a longer pre-surgical seizure duration exhibit a poor outcome, and are more likely to exhibit large epileptogenic zones and more diffuse lesions, which are difficult to eradicate with surgery (32,33). On the basis of these observations, it was hypothesized for the purposes of the present study that epilepsy duration may be a key predictive factor of long-term surgical outcome.

In addition, it was observed that a history of febrile seizures was a predictor for surgical outcome following ALT according to backward logistic analysis. Among the 121 patients were followed up, 63 cases (52.1%) had a history of febrile seizures while 58 (47.9%) had no history of febrile seizures, which is consistent with a previous study by Pavlidou et al (34), in which patients with a history of febrile seizures comprised ~40% of TLE cases, particularly in children aged <4 years (34). Among the 63 patients with a history of febrile seizures, 58 (92.1%) were classified as seizure-free, which was significantly different from the rate among the 58 patients with no history of febrile seizures (29/58, 50.0%). This observation indicates that the structural and functional anatomy of the brain was altered, becoming more susceptible to intractability following febrile seizures (11,27,34).

On the basis of univariate and multivariate analysis, seizure types were found to be associated with long-term surgical outcome evaluated ≤5 years following surgery. A χ2 test revealed statistically significant differences in seizure outcome between simple CPS and frequent CPS or frequent GTCS. Furthermore, it was observed that 19 patients (15.7%) exhibited frequent GTCS, including 7 patients (36.8%) that had a good outcome and 12 patients (63.2%) with a poor outcome. These results indicate that GTCS was associated with a worse outcome. Theoretically, patients with CPS would be expected to exhibit an improved outcome compared with patients with frequent CPS, based on previous studies (13,22). By contrast, it was observed that 57/72 patients (79.2%) with frequent CPS were seizure-free, while 23/30 patients (76.7%) with simple CPS exhibited improved seizure control. This result may be due to epileptogenic zones in patients with GTCS being difficult to localize and resect, resulting in the postoperative formation of a residual epileptogenic area.

With respect to video-EEG results, 72/90 patients (80.0%) with unilateral local lobe involvement, 8/17 patients (47.1%) with unilateral multi-lobe involvement and 7/14 patients (50.0%) with bilateral lobe involvement exhibited a seizure-free outcome. Furthermore, positive video-EEG results were a predictor of surgical outcome, which indicates that patients with unilateral lobe involvement may expect an improved outcome compared with patients with bilateral lobe involvement. Therefore, the present study detected a significant predictive contribution of video-EEG data, particularly in patients with MTLE or with normal MRI results, which is similar to the findings of previous studies (7,10,14,32). However, in other studies, discrepancies between video-EEG and MRI results indicated a poor surgical outcome, which may be due to the existence of bilateral HS or multi-lobe foci (16,35).

Finally, 77/101 patients (76.2%) with positive MRI were seizure-free and 24/101 patients (23.8%) were in the seizure group, indicating that MRI may be useful for the pre-surgical evaluation of epilepsy patients. On the basis of multiple logistic regression analysis, it was determined that the presence of MRI abnormalities was highly predictive of long-term patient outcome. Furthermore, various MRI results, particularly the presence of mesial temporal sclerosis, were identified as predictive of surgical outcomes, which is consistent with previous studies that reported a poor outcome for patients that exhibited no signs of MTLE under MRI (33,3639). In addition, discrepancies between MRI and histopathological results regarding MTLE may be due to the fact that current MRI protocols only provide accurate information in patients with severe bilateral HS or with a significant difference in the bilateral hippocampus. Therefore, the majority of patients with mild unilateral HS and severe contralateral HS are diagnosed with unilateral HS, while patients with mild bilateral HS are considered to be normal (31,35). Although these patients underwent preoperative MRI examinations, for the majority of patients MRI results were not available for each year during the follow-up period. Thus, the structural changes occurring in the brain following surgery are unknown, particularly with respect to the residual hippocampal tissue following ATL, which was a common cause of recurrent seizures, and further studies are required to investigate this in the future.

In the present study, it was demonstrated that the majority of patients with MTLE may be treated effectively with an ATL. A number of pre-surgical factors, including pre-surgical seizure duration, history of febrile convulsion, seizure type, MRI and video-EEG results may be used as predictors of surgical outcomes. Thus, postoperative remission may be achieved in patients with MTLE via the accurate collection of patient information and adequate pre-surgical evaluation. Further studies are required that include a larger group of patients with a longer follow-up period, in order to analyze the rate of late seizure recurrence after an initial seizure-free period. In addition, year-by-year MRI examination and comparisons between MRI and video-EEG results may aid in ascertaining surgical outcomes.

Table IV.

Analysis of identifying variables between seizure-free and seizure groups.

Qualitative variables Seizure-free (n=87) Seizure (n=34) P-value
Pre-surgical duration <10 years 41 23 0.042
Age at surgery <14 years 14   3 0.301
Site of surgery (left temporal) 41 20 0.247
Gender (male) 48 15 0.274
MRI (positive) 77 24 0.017
Presence of auras 43 14 0.414
Past histories 67 16 0.001
  Febrile seizures 58   5 0.001
  Traumatic brain injury 13   6 0.713
  Perinatal anoxia 9   3 1.000
  Family history of seizure   1   1 1.000
  Intracranial infection   6   1 0.686

Pearson's χ2 continuity correction of Fisher's exact test was used for statistical analysis. MRI, magnetic resonance imaging.

Acknowledgements

The authors thank Wenhan Hu and Ning Chen for collecting the data from the archive, as well as Chao Zhang for technical help.

References

  • 1.Engel J., Jr The timing of surgical intervention for mesial temporal lobe epilepsy: A plan for a randomized clinical trial. Arch Neurol. 1999;56:1338–1341. doi: 10.1001/archneur.56.11.1338. [DOI] [PubMed] [Google Scholar]
  • 2.Wieser HG. ILAE commission on neurosurgery of epilepsy: ILAE commission report. Mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsia. 2004;45:695–714. doi: 10.1111/j.0013-9580.2004.09004.x. [DOI] [PubMed] [Google Scholar]
  • 3.Engel J., Jr Mesial temporal lobe epilepsy: What have we learned? Neuroscientist. 2001;7:340–352. doi: 10.1177/107385840100700410. [DOI] [PubMed] [Google Scholar]
  • 4.Wieser HG, Hane A. Antiepileptic drug treatment in seizure-free mesial temporal lobe epilepsy patients with hippocampal sclerosis following selective amygdalohippocampectomy. Seizure. 2004;13:534–536. doi: 10.1016/j.seizure.2003.12.010. [DOI] [PubMed] [Google Scholar]
  • 5.Berkovic SF, McIntosh AM, Kalnins RM. Preoperative MRI predicts outcome of temporal lobectomy: An actuarial analysis. Neurology. 1995;45:1358–1363. doi: 10.1212/WNL.45.7.1358. [DOI] [PubMed] [Google Scholar]
  • 6.McIntosh AM, Wilson SJ, Berkovic SF. Seizure outcome after temporal lobectomy: current research practice and findings. Epilepsia. 2001;42:1288–1307. doi: 10.1046/j.1528-1157.2001.02001.x. [DOI] [PubMed] [Google Scholar]
  • 7.Radhakrishnan K, So EL, Silbert PL, et al. Predictors of outcome of anterior temporal lobectomy for intractable epilepsy: A multivariate study. Neurology. 1998;51:465–471. doi: 10.1212/WNL.51.2.465. [DOI] [PubMed] [Google Scholar]
  • 8.Blume WT, Desai HB, Girvin JP, McLachlan RS, Lemieux JF. Effectiveness of temporal lobectomy measured by yearly follow-up and multivariate analysis. J Epilepsy. 1994;7:203–214. doi: 10.1016/0896-6974(94)90031-0. [DOI] [Google Scholar]
  • 9.Guldvog B, Løyning Y, Hauglie-Hanssen E, Flood S, Bjørnas H. Predictive factors for success in surgical treatment for partial epilepsy: A multivariate analysis. Epilepsia. 1994;35:566–578. doi: 10.1111/j.1528-1157.1994.tb02476.x. [DOI] [PubMed] [Google Scholar]
  • 10.Hennessy MJ, Elwes RD, Rabe-Hesketh S, Binnie CD, Polkey CD. Prognostic factors in the surgical treatment of medically intractable epilepsy associated with mesial temporal sclerosis. Acta Neurol Scand. 2001;103:344–350. doi: 10.1034/j.1600-0404.2001.103006344.x. [DOI] [PubMed] [Google Scholar]
  • 11.Janszky J, Schulz R, Ebner A. Clinical features and surgical outcome of medial temporal lobe epilepsy with a history of complex febrile convulsions. Epilepsy Res. 2003;55:1–8. doi: 10.1016/S0920-1211(03)00087-1. [DOI] [PubMed] [Google Scholar]
  • 12.Specht U, May T, Schulz R, et al. Cerebellar atrophy and prognosis after temporal lobe resection. J Neurol Neurosurg Psychiatry. 1997;62:501–506. doi: 10.1136/jnnp.62.5.501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Semah F, Picot MC, Adam C, et al. Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology. 1998;51:1256–1262. doi: 10.1212/WNL.51.5.1256. [DOI] [PubMed] [Google Scholar]
  • 14.Schulz R, Lüder HO, Hoppe M, Tuxhorn I, May T, Ebner A. Interictal EEG and ictal scalp EEG propagation are highly predictive of surgical outcome in mesial temporal lobe epilepsy. Epilepsia. 2000;41:564–570. doi: 10.1111/j.1528-1157.2000.tb00210.x. [DOI] [PubMed] [Google Scholar]
  • 15.Spencer SS, Berg AT, Vickrey BG, et al. Initial outcomes in the multicenter study of epilepsy surgery. Neurology. 2003;61:1680–1685. doi: 10.1212/01.WNL.0000098937.35486.A3. [DOI] [PubMed] [Google Scholar]
  • 16.Bote RP, Blázquez-Llorca L, Fernández-Gil MA, Alonso-Nanclares L, Muñoz A, De Felipe J. Hippocampal sclerosis: Histopathology substrate and magnetic resonance imaging. Semin Ultrasound CT MR. 2008;29:2–14. doi: 10.1053/j.sult.2007.11.005. [DOI] [PubMed] [Google Scholar]
  • 17.Camacho DLA, Castillo MMR. Imaging of temporal lobe epilepsy. Semin Ultrasound CT and MRI. 2007;28:424–436. doi: 10.1053/j.sult.2007.09.005. [DOI] [PubMed] [Google Scholar]
  • 18.Tanriverdi T, Olivier A, Poulin N, Andermann F, Dubeau F. Long-term seizure outcome after mesial temporal lobe epilepsy surgery: Corticalamygdalohippocampectomy versus selective amygdalohippocampectomy. J Neurosurg. 2008;108:517–524. doi: 10.3171/JNS/2008/108/3/0517. [DOI] [PubMed] [Google Scholar]
  • 19.Bancaud J, Henriksen O, Rubio-Donnadieu F, Seino M, Dreifuss FE, Penry JK. Commission on the Classification and Terminology of the International League Against Epilepsy: Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia. 1981;22:489–501. doi: 10.1111/j.1528-1157.1981.tb06159.x. [DOI] [PubMed] [Google Scholar]
  • 20.Wiebe S, Blume WT, Girvin JP, Eliasziw M. Effectiveness and efficiency of surgery for temporal lobe epilepsy study group. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345:311–318. doi: 10.1056/NEJM200108023450501. [DOI] [PubMed] [Google Scholar]
  • 21.Falconer MA, Taylor DC. Surgical treatment of drug-resistant epilepsy due to mesial temporal sclerosis: Etiology and significance. Arch Neurol. 1968;19:353–361. doi: 10.1001/archneur.1968.00480040019001. [DOI] [PubMed] [Google Scholar]
  • 22.McIntosh AM, Kalnins RM, Michell LA, Berkovic SF. Early seizures after temporal lobectomy predict subsequent seizure recurrence. Ann Neurol. 2005;57:283–288. doi: 10.1002/ana.20372. [DOI] [PubMed] [Google Scholar]
  • 23.Tezera FI, Akalanb N, Oguzc KK, Karabulut E, Dericioglu N, Ciger A, Saygi S. Predictive factors for postoperative outcome in temporal lobe epilepsy according to two different classifications. Seizure. 2008;17:549–560. doi: 10.1016/j.seizure.2008.02.003. [DOI] [PubMed] [Google Scholar]
  • 24.Clusmann H, Schramm J, Kral T, et al. Prognostic factors and outcome after different types of resection for temporal lobe epilepsy. J Neurosurg. 2002;97:1131–1141. doi: 10.3171/jns.2002.97.5.1131. [DOI] [PubMed] [Google Scholar]
  • 25.Zentner J, Hufnagel A, Wolf HK, et al. Surgical treatment of temporal lobe epilepsy: Clinical, radiological and histopathological findings in 178 patients. J Neurol Neurosurg Psychiatry. 1995;58:666–673. doi: 10.1136/jnnp.58.6.666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Jeong SW, Lee SK, Kim KK, Kim H, Kim JY, Chung CK. Prognostic factors in anterior temporal lobe resections for mesial temporal lobe epilepsy: Multivariate analysis. Epilepsia. 1999;40:1735–1739. doi: 10.1111/j.1528-1157.1999.tb01591.x. [DOI] [PubMed] [Google Scholar]
  • 27.Behrens E, Zentner J, van Roost D, Hufnagel A, Elger CE, Schramm J. Subdural and depth electrodes in the presurgical evaluation of epilepsy. Acta Neurochir (Wien) 1994;128:84–87. doi: 10.1007/BF01400656. [DOI] [PubMed] [Google Scholar]
  • 28.Foldvary N, Nashold B, Mascha E, et al. Seizure outcome after temporal lobectomy for temporal lobe epilepsy: A Kaplan-Meier survival analysis. Neurology. 2000;54:630–634. doi: 10.1212/WNL.54.3.630. [DOI] [PubMed] [Google Scholar]
  • 29.Ho SS, Berkovic SF, McKay WJ, Kalnins RM, Bladin PF. Temporal lobe epilepsy subtypes: Differential patterns of cerebral perfusion on ictal SPECT. Epilepsia. 1996;37:788–795. doi: 10.1111/j.1528-1157.1996.tb00653.x. [DOI] [PubMed] [Google Scholar]
  • 30.Clusmann H, Kral T, Fackeldey E, et al. Lesional mesial temporal lobe epilepsy and limited resections: Prognostic factors and outcome. J Neurol Neurosurg Psychiatry. 2004;75:1589–1596. doi: 10.1136/jnnp.2003.024208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Schramm J. Temporal lobe epilepsy surgery and the quest for optimal extent of resection: A review. Epilepsia. 2008;49:1296–1307. doi: 10.1111/j.1528-1167.2008.01604.x. [DOI] [PubMed] [Google Scholar]
  • 32.Holmes MD, Born DE, Kutsy RL, Wilensky AJ, Ojemann GA, Ojemann LM. Outcome after surgery in patients with refractory temporal lobe epilepsy and normal MRI. Seizure. 2000;9:407–411. doi: 10.1053/seiz.2000.0423. [DOI] [PubMed] [Google Scholar]
  • 33.Sperling MR, Saykin AJ, Glosser G, et al. Predictors of outcome after anterior temporal lobectomy: The intracarotid amobarbital test. Neurology. 1994;44:2325–2330. doi: 10.1212/WNL.44.12.2325. [DOI] [PubMed] [Google Scholar]
  • 34.Pavlidou E, Tzitiridou M, Kontopoulos E, Panteliadis CP. Which factors determine febrile seizure recurrence? A prospective study. Brain Dev. 2008;30:7–13. doi: 10.1016/j.braindev.2007.05.001. [DOI] [PubMed] [Google Scholar]
  • 35.Vinton AB, Carne R, Hicks RJ, et al. The extent of resection of FDG-PET hypometabolism relates to outcome of temporal lobectomy. Brain. 2007;130:548–560. doi: 10.1093/brain/awl232. [DOI] [PubMed] [Google Scholar]
  • 36.Antel SB, Li LM, Cendes F, et al. Predicting surgical outcome in temporal lobe epilepsy patients using MRI and MRSI. Neurology. 2002;58:1505–1512. doi: 10.1212/WNL.58.10.1505. [DOI] [PubMed] [Google Scholar]
  • 37.Clusmann H. Predictors, procedures and perspective for temporal lobe epilepsy surgery. Semin Ultrasound CT MR. 2008;29:60–70. doi: 10.1053/j.sult.2007.11.004. [DOI] [PubMed] [Google Scholar]
  • 38.Gilliam F, Bowling S, Bilir E, et al. Association of combined MRI, interictal EEG, and ictal EEG results with outcome and pathology after temporal lobectomy. Epilepsia. 1997;38:1315–1320. doi: 10.1111/j.1528-1157.1997.tb00069.x. [DOI] [PubMed] [Google Scholar]
  • 39.Pillai JJ, Williams HT, Faro S. Functional imaging in temporal lobe epilepsy. Semin Ultrasound CT MR. 2007;28:437–450. doi: 10.1053/j.sult.2007.09.006. [DOI] [PubMed] [Google Scholar]

Articles from Experimental and Therapeutic Medicine are provided here courtesy of Spandidos Publications

RESOURCES